Caporali, R., R. Ravasio, P. Raimondo, and F. Salaffi. “Erratum In: Cost Per Responder for Upadacitinib Vs Abatacept in Patients With Moderate-to-Severe Rheumatoid Arthritis in Italy”. Global and Regional Health Technology Assessment, vol. 9, no. 1, Feb. 2022, p. 30, doi:10.33393/grhta.2022.2383.